Decoy Therapeutics Inc. Accumulated Other Comprehensive Income
Decoy Therapeutics Inc. (DCOY) had Accumulated Other Comprehensive Income of $0 as of 2018-12-31, per its 10-K filed 2019-03-06.
Discontinued › Balance Sheet › Equity, Attributable to Parent
us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax · last filed 2019-03-06
- 2018-12-31: Accumulated Other Comprehensive Income (Loss), Net of Tax $0.00.
- 2018-09-30: Accumulated Other Comprehensive Income (Loss), Net of Tax $0.00.
- 2018-06-30: Accumulated Other Comprehensive Income (Loss), Net of Tax $0.00.
- 2018-03-31: Accumulated Other Comprehensive Income (Loss), Net of Tax $93.00.
| Period end | Accumulated Other Comprehensive Income (Loss), Net of Tax |
|---|---|
| 2018-12-31 | $0.00 10-K · filed 2019-03-06 |
| 2018-09-30 | $0.00 10-Q · filed 2018-11-05 |
| 2018-06-30 | $0.00 10-Q · filed 2018-08-01 |
| 2018-03-31 | $93.00 10-Q · filed 2018-05-02 |
| 2017-12-31 | -$1.25K 10-K · filed 2019-03-06 |
| 2017-09-30 | -$1.31K 10-Q · filed 2017-11-06 |
| 2017-06-30 | -$5.62K 10-Q · filed 2017-08-02 |
| 2017-03-31 | -$12.35K 10-Q · filed 2017-05-03 |
| 2016-12-31 | -$1.61K 10-K · filed 2018-03-07 |
| 2016-09-30 | $14.67K 10-Q · filed 2016-11-02 |
| 2016-06-30 | $39.49K 10-Q · filed 2016-08-03 |
| 2016-03-31 | $19.61K 10-Q · filed 2016-05-04 |
| 2015-12-31 | -$24.65K 10-K · filed 2017-03-08 |
| 2015-09-30 | -$3.68K 10-Q · filed 2015-11-04 |
| 2014-12-31 | $0.00 10-K · filed 2017-03-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Protagenic Therapeutics, Inc.\new (PTIX) | United States | $0.001B | |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |